ATTD International Consensus on the use of CGM
"Periodically, a new idea, method, or tool leads to a turning point in the Management of diabetes. We believe such a moment is now upon us, brought by the development of reliable devices for continuous glucose monitoring (CGM)." - Editorial by Matthew C. Riddle, Hertzel C. Gerstein, and William T. Cefalu, Diabetes Care 2017;40:1611–1613.
At ATTD 2017, an international panel of physicians, researchers, and individuals with diabetes came together for a consensus meeting and addressed the issues around continuous glucose monitoring (CGM).
Even though CGM moves beyond HbA1c measurement, there are issues such as the lack of standardized metrics for analyzing CGM data, and no clear criteria for matching patients to most appropriate glucose monitoring methodologies.
Consensus recommendations and the current understanding of how CGM results can affect outcomes are now summarizes in a publication in Diabetes Care.
ATTD International Consensus on the Use of Continuous Glucose Monitoring.pdf
Diabetes Care is a journal for the health care practitioner that is intended to increase knowledge, stimulate research, and promote better management of people with diabetes.
To achieve these goals, the journal publishes original research on human studies in the following categories: Clinical Care/Education/Nutrition/Psychosocial Research, Epidemiology/Health Services Research, Emerging Treatments and Technologies, Pathophysiology/Complications, and Cardiovascular and Metabolic Risk.
The journal also publishes ADA statements, consensus reports, clinically relevant review articles, letters to the editor, and health/medical news or points of view. Topics covered are of interest to clinically oriented physicians, researchers, epidemiologists, psychologists, diabetes educators, and other health professionals.
touchENDOCRINOLOGY.com is an independent information resource designed to support physicians, clinicians and related healthcare professionals in continuously developing their knowledge, effectiveness and productivity, with open access articles and multimedia content.
European Endocrinology is a peer-reviewed, open access, bi-annual journal comprising review articles, case reports, practice guides, theoretical discussions, and original research. It features balanced and comprehensive articles written by leading authorities, addressing the most important and salient developments in the field of endocrinology.
Hormone Research in Paediatrics
The mission of Hormone Research in Paediatrics is to improve the care of children with endocrine disorders by promoting basic and clinical knowledge. The journal facilitates the dissemination of information through original papers, mini-reviews, clinical guidelines and papers on novel insights from clinical practice.
Data at the frontiers of diabetes research are collected, systematically organized, and critically evaluated by volumes in this series. Contents are based on recent findings published in the medical literature and reflect the most advanced achievements in current clinical and experimental research on diabetes and allied disorders. By giving these data coherent organization and critical interpretation, the editor and authors of ‘Frontiers in Diabetes’ perform a major service for all scientists conducting experimental or clinical work in the field.
Diabetes Technology & Therapeutics
Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and highlights new pharmacological and device developments to optimize patient care.
Diabetes Technology & Therapeutics is under the editorial leadership of Editor-in-Chief Satish K. Garg, MD, University of Colorado Denver, Barbara Davis Center for Childhood Diabetes; Senior Editors Jay S. Skyler, MD, MACP, University of Miami Miller School of Medicine, and Irl B. Hirsch, MD, University of Washington Medical Center–Roosevelt; and other leading investigators.